1. Gallo S, Vanstone CA, Weiler HA. Normative data for bone mass in healthy term infants from birth to 1 year of age. J Osteoporos. 2012; 2012:672403.
2. Koo WW, Bush AJ, Walters J, Carlson SE. Postnatal development of bone mineral status during infancy. J Am Coll Nutr. 1998; 17:65–70.
3. Choi JH, Shin YL, Yoo HW. Short-term efficacy of monthly pamidronate infusion in patients with osteogenesis imperfecta. J Korean Med Sci. 2007; 22:209–212.
4. Forin V. Osteogenesis imperfecta. Presse Med. 2007; 36:1787–1793.
5. Van Dijk FS, Pals G, Van Rijn RR, Nikkels PG, Cobben JM. Classification of osteogenesis imperfecta revisited. Eur J Med Genet. 2010; 53:1–5.
6. Byra P, Chillag S, Petit S. Osteogenesis imperfecta and aortic dissection. Am J Med Sci. 2008; 336:70–72.
7. Badmanaban B, Sachithanandan A, MacGowan SW. Aortic valve replacement in osteogenesis imperfecta: technical and practical considerations for a successful outcome. J Card Surg. 2003; 18:554–556.
8. Kill C, Leonhardt A, Wulf H. Lacticacidosis after short-term infusion of propofol for anaesthesia in a child with osteogenesis imperfecta. Paediatr Anaesth. 2003; 13:823–826.
9. Hwang S, Lee SG, Ahn CS, Moon DB, Kim KH, Ha TY, Song GW. Outflow vein reconstruction of extended right lobe graft using quilt venoplasty technique. Liver Transpl. 2006; 12:156–158.
10. Reed MD, Blumer JL. Propofol bashing: the time to stop is now! Crit Care Med. 1996; 24:175–176.
11. Salehpour S, Tavakkoli S. Cyclic pamidronate therapy in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab. 2010; 23:73–80.
12. Yoon JH, Baek JU, Shim EJ, Hwang IT. Successful pamidronate treatment of osteogenesis imperfecta type III infant with multiple fractures. Ann Pediatr Endocrinol Metab. 2012; 17:194–197.
13. Han EC, Yi NJ, Hong G, Park MS, Choi YR, Kim H, Lee KW, Kim IH, Kim YJ, Ko JS, et al. Serongative acute hepatic failure-associated aplastic anemia in pediatric liver transplantation. J Korean Soc Transplant. 2011; 25:276–281.